Earnshaw S, Brogan A, Wolowacz S. Budget impact analysis II: applications & design issues. Presented at the 2015 ISPOR 18th Annual European Congress; November 2015. Milan, Italy. Previously presented at the ISPOR 20th Annual International Meeting.
Talbird SE, Brogan AJ, La EH, Perard R. Cost-effectiveness analysis of tenofovir/emtricitabine and abacavir/lamivudine in combination with efavirenz or atazanavir/ritonavir for treatment-naïve adults with HIV-1 infection in France and Spain. Poster presented at the Health Technology Assessment international; June 14, 2015. Oslo, Norway.
Earnshaw SR, Brogan AJ, Wolowacz SE. Budget impact analysis II: applications and design issues. Presented at the 2015 ISPOR 20th Annual International Meeting; May 2015. Philadelphia, PA.
Talbird SE, Brogan AJ, Winiarski AP, Sander B. The cost-effectiveness of treating influenza-like illness with oseltamivir in the US. Poster presented at the 42nd Midyear Clinical Meeting of the American Society of Health-System Pharmacists; December 2007.
Leeuwenkamp O, Morlock R, Bell C, Brogan AJ, Mauskopf J. Costs and outcomes of atypical antipsychotics for the treatment of acute schizophrenia. Poster presented at the 2007 ISPOR 10th Annual European Congress; October 24, 2007. [abstract] Value Health. 2007 Nov; 10(6):A301.
Mauskopf J, Brogan AJ, Malmberg C, Hwang P. Cost-effectiveness of darunavir for the management of HIV-infected, treatment-experienced adults in Canada. Poster presented at the 2007 ISPOR 12th Annual International Meeting; May 22, 2007. Previously presented at the 16th Annual Canadian Conference on HIV/AIDS Research.
Mauskopf JA, Brogan AJ, Malmberg C, Hwang P. A Canadian cost-effectiveness analysis of darunavir for HIV infection in treatment-experienced adults. Poster presented at the 2007 ISPOR 12th Annual International Meeting; May 2007. Arlington, VA. [abstract] Value Health. 2007 May; 10(3):A163.
Brogan AJ, Mauskopf JA, Martin S, Smets E. Cost-effectiveness analysis of darunavir/r for HIV infection in treatment-experienced adults in the US: understanding the uncertainty in the estimates. Poster presented at the 2007 ISPOR 12th Annual International Meeting; May 2007. Arlington, VA.
Mauskopf J, Brogan AJ, Malmberg C, Hwang P. Cost-effectiveness of darunavir for the management of HIV-infected, treatment-experienced adults in Canada. Poster presented at the 16th Annual Canadian Conference on HIV/AIDS Research; April 29, 2007.
Earnshaw SR, Brogan AJ. Markov-model toolkit: concepts and assumptions. Presented at the 19th Annual Meeting and Showcase of the Academy of Managed Care Pharmacy; April 2007. San Diego, CA.